MARKET

MEDP

MEDP

Medpace Holdings
NASDAQ
421.87
+1.96
+0.47%
After Hours: 423.00 +1.13 +0.27% 19:12 05/20 EDT
OPEN
417.00
PREV CLOSE
419.91
HIGH
422.42
LOW
403.46
VOLUME
376.20K
TURNOVER
--
52 WEEK HIGH
628.92
52 WEEK LOW
287.17
MARKET CAP
12.05B
P/E (TTM)
26.54
1D
5D
1M
3M
1Y
5Y
1D
MEDP Investors Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit
PR Newswire · 5h ago
Medpace Holdings, Inc. (MEDP) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
PR Newswire · 15h ago
Medpace shareholders approve governance changes enhancing voting rights
TipRanks · 1d ago
Medpace Holdings shareholders approve charter amendments removing supermajority voting requirements
PUBT · 1d ago
MEDP Deadline Alert: Medpace Investors with Losses are Notified of the Pending Securities Fraud Class Action Over Alleged Misrepresentations
PR Newswire · 1d ago
How Investors Are Reacting To Medpace Holdings (MEDP) Fraud Suits Over Backlog And Book-to-Bill Disclosures
Simply Wall St · 2d ago
Weekly Report: what happened at MEDP last week (0511-0515)?
Weekly Report · 2d ago
INVESTOR NOTICE: Medpace Holdings Inc. (MEDP) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Barchart · 5d ago
More
About MEDP
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company’s drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company’s operations are principally based in North America, Europe, and Asia.

Webull offers Medpace Holdings Inc stock information, including NASDAQ: MEDP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MEDP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MEDP stock methods without spending real money on the virtual paper trading platform.